Shares of Nvidia-backed Recursion Pharmaceuticals Inc. (RXRX) ended Friday lower, extending weekly losses past 21% after missing Wall Street estimates on both revenue and profit in its latest ...

The PIK3CA gene, which encodes the p110α subunit of phosphoinositide 3-kinase (PI3K), is among the most frequently mutated oncogenes in cancer. These mutations drive tumor progression ...

At Recursion's recent [Learnings] Call, Co-Founder and CEO Chris Gibson welcomed investors and analysts to share exciting updates on the company's progress in decoding biology to change the way drugs ...

Cell lines with increased PI3K/AKT activity were resistant to trastuzumab ... a truncated HER2 with intact kinase activity, were not associated with trastuzumab response; however, lapatinib ...

Researchers sought to evaluate differences in ctDNA profiles, use of targeted treatments, and overall survival between Black and White patients with metastatic breast cancer.